Table 2.
Gene | SNP | Genotype | HR(95%‐CI)h | P a | pFDR b | pTrend c | pTrend‐FDR d | pGenewide‐FDR e | |
---|---|---|---|---|---|---|---|---|---|
Overall Survival | PON1 | rs3917538 | C/C | ref | <0.01 | <0.01 | <0.01 | ||
C/T | 1.18 (0.97–1.43) | 0.09 | |||||||
T/T | 2.02 (1.46–2.80) | <0.01 | |||||||
C/T or T/Tf | 1.28 (1.07–1.53) | <0.01 | 0.59 | 0.04 | |||||
TYMS | rs1001761g | C/C | ref | 0.04 | 0.73 | 0.11 | |||
C/T | 0.84 (0.68–1.02) | 0.08 | |||||||
T/T | 0.77 (0.59–1.00) | 0.05 | |||||||
C/T or T/Tf | 0.82 (0.68–0.99) | 0.04 | 0.59 | 0.09 | |||||
TYMS | rs2847149g | G/G | ref | 0.04 | 0.73 | 0.11 | |||
G/A | 0.84 (0.68–1.02) | 0.08 | |||||||
A/A | 0.77 (0.59–1.00) | 0.02 | |||||||
G/A or A/Af | 0.82 (0.68–0.99) | 0.04 | 0.59 | 0.09 | |||||
TYMS | rs495139 | C/C | ref | 0.07 | 0.79 | 0.11 | |||
C/G | 1.48 (1.20–1.82) | <0.01 | |||||||
G/G | 1.17 (0.89–1.53) | 0.27 | |||||||
C/G or G/Gf | 1.39 (1.14–1.69) | <0.01 | 0.45 | <0.01 | |||||
Disease‐free survival | MAT2B | rs6882306 | T/T | ref | <0.01 | 0.45 | 0.01 | ||
T/C | 1.31 (1.05–1.62) | 0.01 | |||||||
C/C | 1.91 (1.15–3.16) | 0.01 | |||||||
T/C or C/Cf | 1.35 (1.10–1.66) | <0.01 | 0.84 | 0.02 | |||||
UMPS | rs1162 | A/A | ref | <0.01 | 0.60 | 0.02 | |||
A/G | 1.22 (0.99–1.50) | 0.06 | |||||||
G/G | 1.57 (1.15–2.13) | <0.01 | |||||||
A/G or G/Gf | 1.29 (1.06–1.57) | 0.01 | 0.84 | 0.07 |
p:P‐value for log‐additive and dominant model.
pFDR:FDR‐adjusted.
pTrend:P‐value trend.
pTrend‐FDR:FDR‐adjusted trend.
pGenewide‐FDR:FDR‐adjusted genewide effect.
Dominant model, (HRhet).
Candidate, FDR‐adjusted cutoff for significance of P‐value = 0.01.
Adjusted for age, sex, stage, grade, BMI, alcohol intake.
P‐values in bold are statistically significant.